Nabriva Therapeutics PLC - ADR (NBRV) has gained Monday morning, with the stock increasing 3.88% in pre-market trading to 1.07. NBRV's short-term technical score of 0 indicates that the stock has traded less bullishly over the last month than 100% of stocks on the market. In the Biotechnology industry, which ranks 141 out of 146 industries, Nabriva Therapeutics PLC - ADR ranks higher than 0% of stocks. Nabriva Therapeutics PLC - ADR has fallen 12.71% over the past month, closing at $1.21 on October 18. During this period of time, the stock fell as low as $1.03 and as high as $1.40. NBRV has an average analyst recommendation of Buy. The company has an average price target of $2.68.
NBRV has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on NBRV!